Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
Your view on FSNUY
Overview
What the company does, where it operates, and who runs it.
About Fresenius SE & Co. KGaA
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Michael Sen
- Headquarters
- Else-Kroener-Strasse 1, Bad Homburg vor der Höhe, DE
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Michael Sen
- Headquarters
- Else-Kroener-Strasse 1, Bad Homburg vor der Höhe, DE
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.
The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients.
This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies.
The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain.
This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities.
This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services.
The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Fresenius SE & Co. KGaA, and the rating behind it. FSNUY last traded at $15.10, 16.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Fresenius SE & Co. KGaA. Starting points for Fresenius SE & Co. KGaA: P/E 16.4, EPS $0.68, beta 0.90 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Fresenius SE & Co. KGaA. Fresenius SE & Co. KGaA does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Fresenius SE & Co. KGaA. Trailing twelve-month EPS for Fresenius SE & Co. KGaA stands at $0.68. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Fresenius SE & Co. KGaA. Fresenius SE & Co. KGaA has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Fresenius SE & Co. KGaA valued side by side against its closest peers. Fresenius SE & Co. KGaA is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Fresenius SE & Co. KGaA, and how their positions are changing. At a $136.08B market value, institutional positions materially move Fresenius SE & Co. KGaA's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Fresenius SE & Co. KGaA executives and directors. Shares of Fresenius SE & Co. KGaA have traded between $9.56 and $33.93 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Fresenius SE & Co. KGaA. Fresenius SE & Co. KGaA is a $136.08B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Fresenius SE & Co. KGaA. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Fresenius SE & Co. KGaA. Coverage tracks Fresenius SE & Co. KGaA within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.